Luncheon Seminar

LS2-9

Current therapeutic issues and future prospects for Acute Myeloid Leukemia.
～New therapeutic strategy with FLT3 inhibitor guilterinib ～

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Nobuhiko Emi (Department of Hematology, Fujita Health University)

Sponsor: Astellas Pharma Inc.

Luncheon Seminar

LS2-10

Involvement of the immune system in hematologic malignancies

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Hiroshi Fujiwara (Mie University Graduate School of Medicine, Department of Personalized Cancer Immunotherapy, Center for Comprehensive Cancer Immunotherapy)

Sponsor: Bristol-Myers Squibb K.K.

Luncheon Seminar

LS2-11

Role of Bosutinib in the treatment of CML

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Kinuko Mitani (Department of Hematology and Oncology, Dokkyo Medical University School of Medicine)

Sponsor: Pfizer Japan Inc.

Luncheon Seminar

LS2-12

Infectious Diseases in Children with Hematological Disorders

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Shouichi Ohga (Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University)

Sponsor: SHIONOGI & CO., LTD.

Luncheon Seminar

LS2-13

How I treat chronic ITP: splenectomy vs medication

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Kingo Fujimura (Yasuda Women’s University, Faculty of Nursing, Department of Nursing)

Sponsor: ZENYAKU KOGYO Co., Ltd.

Luncheon Seminar

LS2-14

Eculizumab Application to PNH treatment: Risk of Meningococcal Infection that Hematologists should look out for

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Michihide Tokuhira (Saitama Medical Center, Saitama Medical University)

Sponsor: Alexion Pharma G.K.

Luncheon Seminar

LS2-15

Management of fungal infections in patients with hematological diseases

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Akiyoshi Takami (Division of Hematology, Department of Internal Medicine, Aichi Medical University)

Sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Luncheon Seminar

LS3-1

New Treatment Strategies for R/R ALL
～ Blinatumomab:Bispecific T-Cell Engager(BiTE®) as new immunotherapy ～

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.1 (Osaka International Convention Center, 5F Main Hall)

Chair: Yukio Kobayashi (International University of Health and Welfare, Mita Hospital)

Sponsors: Amgen Astellas BioPharma K.K./Astellas Pharma Inc.

Luncheon Seminar

LS3-3

Therapeutic Targeting of Acute Myeloid Leukemia Stem Cells

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Koichi Akashi (Dept. of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University, Japan)

Sponsor: AbbVie GK

Luncheon Seminar

LS3-4

Future perspective of allogeneic hematopoietic transplantation for acute myeloid leukemia

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Shinichiro Okamoto (Division of Hematology Department of Internal Medicine, Keio University School of Medicine)

Sponsor: Fuji Pharma Co., Ltd